2023
DOI: 10.1002/jso.27242
|View full text |Cite
|
Sign up to set email alerts
|

Neoadjuvant chemotherapy does not increase risk for anastomotic leak for simultaneous resection of primary colon cancer with synchronous liver metastasis: A NSQIP‐colectomy analysis

Abstract: Background and Objectives In patients with colon cancer with synchronous liver metastasis, treatment algorithms are complex and often require multidisciplinary evaluation. Neoadjuvant therapy is frequently utilized, but there is an unclear relationship with postoperative outcomes in patients with simultaneous resection. Methods This is a retrospective cohort study from the National Surgical Quality Improvement Program and Targeted Colectomy databases. All patients with stage IV colon cancer undergoing simultan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…Patients with synchronous liver metastases (which accounted for 80% of patients with Stage IV colon cancer) were compared between those who had surgery upfront versus those who had neoadjuvant chemotherapy followed by surgery, and they found no difference in anastomotic leak in both univariate and multivariate analysis. 48 Cheong et al, in their meta-analysis of five RCTs and two observational studies examining the effects of neoadjuvant therapy for locally advanced colon cancer also concurred that there was no associated increase anastomotic leak rates (relative risk of 0.83, p = 0.42). 49 https://doi.org/10.2147/OAS.S429415…”
Section: Local Factors Locally Advanced or Metastatic Diseasementioning
confidence: 92%
“…Patients with synchronous liver metastases (which accounted for 80% of patients with Stage IV colon cancer) were compared between those who had surgery upfront versus those who had neoadjuvant chemotherapy followed by surgery, and they found no difference in anastomotic leak in both univariate and multivariate analysis. 48 Cheong et al, in their meta-analysis of five RCTs and two observational studies examining the effects of neoadjuvant therapy for locally advanced colon cancer also concurred that there was no associated increase anastomotic leak rates (relative risk of 0.83, p = 0.42). 49 https://doi.org/10.2147/OAS.S429415…”
Section: Local Factors Locally Advanced or Metastatic Diseasementioning
confidence: 92%